Literature DB >> 18400190

Cytokine signaling modules in inflammatory responses.

John J O'Shea1, Peter J Murray.   

Abstract

Cytokine signaling via a restricted number of Jak-Stat pathways positively and negatively regulates all cell types involved in the initiation, propagation, and resolution of inflammation. Here, we focus on Jak-Stat signaling in three major cell types involved in inflammatory responses: T cells, neutrophils, and macrophages. We summarize how the Jak-Stat pathways in these cells are negatively regulated by the Suppressor of cytokine signaling (Socs) proteins. We emphasize that common Jak-Stat-Socs signaling modules can have diverse developmental, pro- and anti-inflammatory outcomes depending on the cytokine receptor activated and which genes are accessible at a given time in a cell's life. Because multiple components of Jak-Stat-Socs pathways are mutated or closely associated with human inflammatory diseases, and cytokine-based therapies are increasingly deployed to treat inflammation, understanding cytokine signaling will continue to advance our ability to manipulate chronic and acute inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400190      PMCID: PMC2782488          DOI: 10.1016/j.immuni.2008.03.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  101 in total

Review 1.  Molecular phylogeny within type I cytokines and their cognate receptors.

Authors:  Jean-Louis Boulay; John J O'Shea; William E Paul
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 2.  Th17 cells: effector T cells with inflammatory properties.

Authors:  Thomas Korn; Mohamed Oukka; Vijay Kuchroo; Estelle Bettelli
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

3.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Authors:  Shean J Aujla; Yvonne R Chan; Mingquan Zheng; Mingjian Fei; David J Askew; Derek A Pociask; Todd A Reinhart; Florencia McAllister; Jennifer Edeal; Kristi Gaus; Shahid Husain; James L Kreindler; Patricia J Dubin; Joseph M Pilewski; Mike M Myerburg; Carol A Mason; Yoichiro Iwakura; Jay K Kolls
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

4.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Authors:  Peter K K Wong; Paul J Egan; Ben A Croker; Kristy O'Donnell; Natalie A Sims; Sarah Drake; Hiu Kiu; Edward J McManus; Warren S Alexander; Andrew W Roberts; Ian P Wicks
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

5.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  Metal chelation and inhibition of bacterial growth in tissue abscesses.

Authors:  Brian D Corbin; Erin H Seeley; Andrea Raab; Joerg Feldmann; Michael R Miller; Victor J Torres; Kelsi L Anderson; Brian M Dattilo; Paul M Dunman; Russell Gerads; Richard M Caprioli; Wolfgang Nacken; Walter J Chazin; Eric P Skaar
Journal:  Science       Date:  2008-02-15       Impact factor: 47.728

7.  SOCS3 regulates the plasticity of gp130 signaling.

Authors:  Roland Lang; Anne-Laure Pauleau; Evan Parganas; Yutaka Takahashi; Jörg Mages; James N Ihle; Robert Rutschman; Peter J Murray
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

8.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Authors:  Hideo Yasukawa; Masanobu Ohishi; Hiroyuki Mori; Masaaki Murakami; Takatoshi Chinen; Daisuke Aki; Toshikatsu Hanada; Kiyoshi Takeda; Shizuo Akira; Masahiko Hoshijima; Toshio Hirano; Kenneth R Chien; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

9.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

10.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

View more
  281 in total

1.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

3.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.

Authors:  Seemal R Desai; Ilona J Frieden; Joel M Gelfand; Whitney High; Arthur Kavanaugh; Ashfaq A Marghoob; David M Ozog; Ted Rosen; Linda Stein Gold; Bruce Strober; Neil Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

4.  Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function.

Authors:  F Perner; T M Schnöder; S Ranjan; D Wolleschak; C Ebert; M C Pils; S Frey; A Polanetzki; C Fahldieck; U Schönborn; B Schraven; B Isermann; T Fischer; F H Heidel
Journal:  Leukemia       Date:  2015-08-05       Impact factor: 11.528

Review 5.  Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.

Authors:  Ali Raza; Wajeeha Yousaf; Ralph Giannella; Mohamed Tarek Shata
Journal:  Expert Rev Clin Immunol       Date:  2012-02       Impact factor: 4.473

Review 6.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

7.  sNASP inhibits TLR signaling to regulate immune response in sepsis.

Authors:  Feng-Ming Yang; Yong Zuo; Wei Zhou; Chuan Xia; Bumsuk Hahm; Mark Sullivan; Jinke Cheng; Hui-Ming Chang; Edward Th Yeh
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics.

Authors:  Fadia F Mahmoud; David Haines; Ali A Dashti; Sherief El-Shazly; Fawzia Al-Najjar
Journal:  Cell Stress Chaperones       Date:  2018-05-11       Impact factor: 3.667

Review 9.  Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 10.  Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages.

Authors:  Robert D Stout; Stephanie K Watkins; Jill Suttles
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.